Thanks J8/Hoyland. I'm a slow learner sometimes. I went back and listened to the presentation from the 2013 roadshow presentation and that confirms what you said. Interestingly, in that presentation, Peter French says that the first cohort get a sub-therapeutic dose, but that the second cohort get a low therapeutic dose, so hopefully we see some decrease in viral load with the second cohort of 3 patients.
time for a reality check, page-36
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)